In this report, the United States Non-opioid Analgesic Patch market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Non-opioid Analgesic Patch in these regions, from 2012 to 2022 (forecast). United States Non-opioid Analgesic Patch market competition by top manufacturers/players, with Non-opioid Analgesic Patch sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including GlaxoSmithKline Plc Pfizer, Inc. Teikoku Seiyaku Co., Ltd. Mylan N.V. Hisamitsu Pharmaceutical Co.,Inc Acorda Therapeutics, Inc Endo International plc Allergan Teh Seng Pharmaceutical Mfg IBSA Institut Biochimque SA On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Hospital Pharmacies Online Pharmacies Independent Pharmacies & Drug Stores If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents United States Non-opioid Analgesic Patch Market Report 2017 1 Non-opioid Analgesic Patch Overview 1.1 Product Overview and Scope of Non-opioid Analgesic Patch 1.2 Classification of Non-opioid Analgesic Patch by Product Category 1.2.1 United States Non-opioid Analgesic Patch Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Non-opioid Analgesic Patch Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 Lidocaine Patches 1.2.4 Diclofenac Patches 1.2.5 Methyl Salicylate Patches 1.2.6 Capsaicin Patches 1.2.7 Ketoprofen Patches 1.2.8 Others 1.3 United States Non-opioid Analgesic Patch Market by Application/End Users 1.3.1 United States Non-opioid Analgesic Patch Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Independent Pharmacies & Drug Stores 1.4 United States Non-opioid Analgesic Patch Market by Region 1.4.1 United States Non-opioid Analgesic Patch Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Non-opioid Analgesic Patch Status and Prospect (2012-2022) 1.4.3 Southwest Non-opioid Analgesic Patch Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Non-opioid Analgesic Patch Status and Prospect (2012-2022) 1.4.5 New England Non-opioid Analgesic Patch Status and Prospect (2012-2022) 1.4.6 The South Non-opioid Analgesic Patch Status and Prospect (2012-2022) 1.4.7 The Midwest Non-opioid Analgesic Patch Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Non-opioid Analgesic Patch (2012-2022) 1.5.1 United States Non-opioid Analgesic Patch Sales and Growth Rate (2012-2022) 1.5.2 United States Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2022) 2 United States Non-opioid Analgesic Patch Market Competition by Players/Suppliers 2.1 United States Non-opioid Analgesic Patch Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Non-opioid Analgesic Patch Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Non-opioid Analgesic Patch Average Price by Players/Suppliers (2012-2017) 2.4 United States Non-opioid Analgesic Patch Market Competitive Situation and Trends 2.4.1 United States Non-opioid Analgesic Patch Market Concentration Rate 2.4.2 United States Non-opioid Analgesic Patch Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Non-opioid Analgesic Patch Manufacturing Base Distribution, Sales Area, Product Type 3 United States Non-opioid Analgesic Patch Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Non-opioid Analgesic Patch Sales and Market Share by Region (2012-2017) 3.2 United States Non-opioid Analgesic Patch Revenue and Market Share by Region (2012-2017) 3.3 United States Non-opioid Analgesic Patch Price by Region (2012-2017) 4 United States Non-opioid Analgesic Patch Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Non-opioid Analgesic Patch Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Non-opioid Analgesic Patch Revenue and Market Share by Type (2012-2017) 4.3 United States Non-opioid Analgesic Patch Price by Type (2012-2017) 4.4 United States Non-opioid Analgesic Patch Sales Growth Rate by Type (2012-2017) 5 United States Non-opioid Analgesic Patch Sales (Volume) by Application (2012-2017) 5.1 United States Non-opioid Analgesic Patch Sales and Market Share by Application (2012-2017) 5.2 United States Non-opioid Analgesic Patch Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Non-opioid Analgesic Patch Players/Suppliers Profiles and Sales Data 6.1 GlaxoSmithKline Plc 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Pfizer, Inc. 6.2.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Teikoku Seiyaku Co., Ltd. 6.3.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Mylan N.V. 6.4.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Hisamitsu Pharmaceutical Co.,Inc 6.5.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Acorda Therapeutics, Inc 6.6.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Endo International plc 6.7.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Allergan 6.8.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Teh Seng Pharmaceutical Mfg 6.9.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 IBSA Institut Biochimque SA 6.10.2 Non-opioid Analgesic Patch Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 7 Non-opioid Analgesic Patch Manufacturing Cost Analysis 7.1 Non-opioid Analgesic Patch Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Non-opioid Analgesic Patch Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Non-opioid Analgesic Patch Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Non-opioid Analgesic Patch Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Non-opioid Analgesic Patch Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Non-opioid Analgesic Patch Sales Volume Forecast by Type (2017-2022) 11.3 United States Non-opioid Analgesic Patch Sales Volume Forecast by Application (2017-2022) 11.4 United States Non-opioid Analgesic Patch Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer